302 related articles for article (PubMed ID: 30411991)
1. Enhancing oral bioavailability of poorly soluble drugs with mesoporous silica based systems: opportunities and challenges.
Bremmell KE; Prestidge CA
Drug Dev Ind Pharm; 2019 Mar; 45(3):349-358. PubMed ID: 30411991
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica materials: From physico-chemical properties to enhanced dissolution of poorly water-soluble drugs.
Maleki A; Kettiger H; Schoubben A; Rosenholm JM; Ambrogi V; Hamidi M
J Control Release; 2017 Sep; 262():329-347. PubMed ID: 28778479
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous Silica Molecular Sieve based Nanocarriers: Transpiring Drug Dissolution Research.
Pattnaik S; Pathak K
Curr Pharm Des; 2017; 23(3):467-480. PubMed ID: 27784249
[TBL] [Abstract][Full Text] [Related]
4. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
5. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
6. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
Hate SS; Reutzel-Edens SM; Taylor LS
Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
[TBL] [Abstract][Full Text] [Related]
8. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
9. Applications of mesoporous materials as excipients for innovative drug delivery and formulation.
Shen SC; Ng WK; Chia LS; Dong YC; Tan RB
Curr Pharm Des; 2013; 19(35):6270-89. PubMed ID: 23470004
[TBL] [Abstract][Full Text] [Related]
10. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
[TBL] [Abstract][Full Text] [Related]
11. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
Dening TJ; Taylor LS
Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
[TBL] [Abstract][Full Text] [Related]
12. Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.
Vialpando M; Martens JA; Van den Mooter G
Ther Deliv; 2011 Aug; 2(8):1079-91. PubMed ID: 22833866
[TBL] [Abstract][Full Text] [Related]
13. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
[TBL] [Abstract][Full Text] [Related]
14. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery.
Baumgartner A; Planinšek O
Eur J Pharm Sci; 2021 Dec; 167():106015. PubMed ID: 34547382
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry.
Meola TR; Schultz HB; Peressin KF; Prestidge CA
Eur J Pharm Sci; 2020 Jul; 150():105357. PubMed ID: 32446169
[TBL] [Abstract][Full Text] [Related]
16. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
[TBL] [Abstract][Full Text] [Related]
17. Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading.
Schultz HB; Thomas N; Rao S; Prestidge CA
Eur J Pharm Biopharm; 2018 Apr; 125():13-20. PubMed ID: 29277724
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Evaluation of Core-Shell Mesoporous Silica as a Promising Water-Insoluble Drug Delivery System: Improving the Dissolution Rate and Bioavailability of Celecoxib With Needle-Like Crystallinity.
Han C; Zhang S; Huang H; Dong Y; Sui X; Jian B; Zhu W
J Pharm Sci; 2019 Oct; 108(10):3225-3232. PubMed ID: 31226426
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica-based dosage forms improve release characteristics of poorly soluble drugs: case example fenofibrate.
Dressman JB; Herbert E; Wieber A; Birk G; Saal C; Lubda D
J Pharm Pharmacol; 2016 May; 68(5):634-45. PubMed ID: 26255860
[TBL] [Abstract][Full Text] [Related]
20. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
Yasmin R; Rao S; Bremmell K; Prestidge C
Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
